Alembic Pharmaceuticals moves up on getting USFDA’s nod for Dabigatran Etexilate Capsules

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 873.20, up by 5.75 points or 0.66% from its previous closing of Rs. 867.45 on the BSE. The scrip opened at Rs. 883.25 and has touched a high and low of Rs. 894.00 and Rs. 871.00 respectively. So far 3239 shares were traded on the counter. The BSE … Read more

Alembic Pharma rises on getting tentative USFDA’s nod for breast cancer drug

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 1013.55, up by 8.70 points or 0.87% from its previous closing of Rs. 1004.85 on the BSE. The scrip opened at Rs. 1008.95 and has touched a high and low of Rs. 1035.00 and Rs. 1003.80 respectively. So far 3128 shares were traded on the counter. The BSE … Read more

Alembic Pharmaceuticals rises on getting USFDA’s tentative approval for Brexpiprazole Tablets

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 519.05, up by 6.75 points or 1.32% from its previous closing of Rs. 512.30 on the BSE. The scrip opened at Rs. 512.55 and has touched a high and low of Rs. 519.05 and Rs. 512.55 respectively. So far 331 shares were traded on the counter. The BSE … Read more

Alembic Pharmaceuticals gets final nod for Fulvestrant Injection from USFDA

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per SingleDose Prefilled Syringe. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Faslodex Injection, 250 mg/5 mL (50 mg/mL), of AstraZeneca Pharmaceuticals … Read more

Alembic Pharmaceuticals gets USFDA’s final approval for Cyclophosphamide Capsules

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide Capsules, 25 mg and 50 mg. he approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Cyclophosphamide Capsules, 25 mg and 50 mg, of Hikma Pharmaceuticals USA Inc. Cyclophosphamide … Read more

Alembic Pharmaceuticals zooms on getting final nod for Ketorolac Tromethamine Injection

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 661.55, up by 49.35 points or 8.06% from its previous closing of Rs. 612.20 on the BSE. The scrip opened at Rs. 608.70 and has touched a high and low of Rs. 675.00 and Rs. 603.55 respectively. So far 143890 shares were traded on the counter. The BSE … Read more

BREAKING NEWS:
Vaibhav Suryaavanshi Receives SUV for IPL Record-Storm! Convert WhatsApp Voice Messages to Text Easily! Actress Nehal Vadoliya loses control in intimate bedroom scenes.